DK1101770T3 - Derivativer af 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]carbazol og 12,13-(pyranosyl)-furo[3,4-c]indol[2,3-a]carbazol, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Derivativer af 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]carbazol og 12,13-(pyranosyl)-furo[3,4-c]indol[2,3-a]carbazol, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK1101770T3
DK1101770T3 DK00403107T DK00403107T DK1101770T3 DK 1101770 T3 DK1101770 T3 DK 1101770T3 DK 00403107 T DK00403107 T DK 00403107T DK 00403107 T DK00403107 T DK 00403107T DK 1101770 T3 DK1101770 T3 DK 1101770T3
Authority
DK
Denmark
Prior art keywords
carbazole
alkyl
nrarb
aryl
indolo
Prior art date
Application number
DK00403107T
Other languages
Danish (da)
English (en)
Inventor
Michelle Prudhomme
Pascale Moreau
Fabrice Anizon
Christelle Marminon
Ghanem Atassi
Alain Pierre
Bruno Pfeiffer
Pierre Renard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1101770T3 publication Critical patent/DK1101770T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK00403107T 1999-11-17 2000-11-09 Derivativer af 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]carbazol og 12,13-(pyranosyl)-furo[3,4-c]indol[2,3-a]carbazol, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse DK1101770T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914433A FR2801054B1 (fr) 1999-11-17 1999-11-17 Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1101770T3 true DK1101770T3 (da) 2003-08-04

Family

ID=9552202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00403107T DK1101770T3 (da) 1999-11-17 2000-11-09 Derivativer af 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]carbazol og 12,13-(pyranosyl)-furo[3,4-c]indol[2,3-a]carbazol, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse

Country Status (23)

Country Link
US (1) US6569858B2 (ja)
EP (1) EP1101770B1 (ja)
JP (1) JP3602050B2 (ja)
KR (1) KR100453980B1 (ja)
CN (1) CN1152040C (ja)
AT (1) ATE237625T1 (ja)
AU (1) AU771584B2 (ja)
BR (1) BR0005426A (ja)
CA (1) CA2325779C (ja)
DE (1) DE60002142T2 (ja)
DK (1) DK1101770T3 (ja)
EA (1) EA004737B1 (ja)
ES (1) ES2197061T3 (ja)
FR (1) FR2801054B1 (ja)
HK (1) HK1036991A1 (ja)
HU (1) HUP0004574A3 (ja)
MX (1) MXPA00010899A (ja)
NO (1) NO20005796L (ja)
NZ (1) NZ508231A (ja)
PL (1) PL343879A1 (ja)
PT (1) PT1101770E (ja)
SI (1) SI1101770T1 (ja)
ZA (1) ZA200006729B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) * 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
BR0208322A (pt) 2001-03-22 2004-10-13 Bristol Myers Squibb Co Derivados de açúcar citotóxixo seletivo da topoisomerase i de indolopirrolocarbazóis
FR2826653B1 (fr) 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2831169B1 (fr) * 2001-10-22 2003-12-12 Servier Lab Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2326459B1 (es) * 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN104031052B (zh) * 2014-05-20 2016-06-08 中国科学院南海海洋研究所 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
AU2019309894A1 (en) 2018-07-27 2021-01-28 Biotheryx, Inc. Bifunctional compounds as CDK modulators
RU2726801C1 (ru) * 2019-10-16 2020-07-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) Средство для терапии опухолей
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
JPH05140168A (ja) * 1991-11-13 1993-06-08 Asahi Chem Ind Co Ltd インドロカルバゾール誘導体及び該化合物を有効成分とする抗腫瘍剤
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JPH07112987A (ja) * 1993-10-14 1995-05-02 Asahi Chem Ind Co Ltd スタウロスポリン糖部分変換誘導体
CO4940430A1 (es) * 1997-07-07 2000-07-24 Novartis Ag Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales

Also Published As

Publication number Publication date
NO20005796D0 (no) 2000-11-16
EA004737B1 (ru) 2004-08-26
HUP0004574A2 (hu) 2001-10-28
US20020055510A1 (en) 2002-05-09
KR100453980B1 (ko) 2004-10-20
MXPA00010899A (es) 2002-05-23
AU771584B2 (en) 2004-03-25
FR2801054A1 (fr) 2001-05-18
HK1036991A1 (en) 2002-01-25
NO20005796L (no) 2001-05-18
CN1303859A (zh) 2001-07-18
PL343879A1 (en) 2001-05-21
ES2197061T3 (es) 2004-01-01
AU7168100A (en) 2002-01-03
KR20010051775A (ko) 2001-06-25
BR0005426A (pt) 2001-07-03
ATE237625T1 (de) 2003-05-15
HUP0004574A3 (en) 2001-12-28
FR2801054B1 (fr) 2003-06-13
SI1101770T1 (en) 2003-08-31
NZ508231A (en) 2001-09-28
CN1152040C (zh) 2004-06-02
CA2325779C (fr) 2006-07-11
US6569858B2 (en) 2003-05-27
HU0004574D0 (ja) 2001-02-28
EP1101770A1 (fr) 2001-05-23
EA200001078A1 (ru) 2001-06-25
ZA200006729B (en) 2001-06-05
JP2001139578A (ja) 2001-05-22
PT1101770E (pt) 2003-07-31
DE60002142T2 (de) 2004-03-18
CA2325779A1 (fr) 2001-05-17
JP3602050B2 (ja) 2004-12-15
DE60002142D1 (de) 2003-05-22
EP1101770B1 (fr) 2003-04-16

Similar Documents

Publication Publication Date Title
DK1101770T3 (da) Derivativer af 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]carbazol og 12,13-(pyranosyl)-furo[3,4-c]indol[2,3-a]carbazol, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse
MX9202856A (es) Derivados de imidazo [1,2-b][3]benzoazepina, composiciones y metodo de uso.
AU6607901A (en) Azaindole derivatives, process for their preparation, and their use as antitumoragents
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
MA22554A1 (fr) Derives d'imidazo (1,2-a) (pyrrolo, thieno ou furano) (3,2-d) azepines, compositions les renfermant et methodes pour leur utilisation
HUT47580A (en) Process for production of tricycle oxindole derivatives decreasing inflammation
DK0458624T3 (da) Fremgangsmåde til fremstilling af lactamderivater
NO20000605L (no) 3-Substituerte 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]tieno[2,3- D]pyrimidinderivater, deres fremstilling og anvendelse som 5HT- antagonister
DE69332929D1 (de) ANTIALLERGISCHE IMIDAZO[1,2-a]THIENO[2,3-d]AZEPINDERIVATE
NZ331267A (en) Bis-pyrido[4,3-b] carbazole compounds of the olivacine and ellipticine family, a process for making them, compositions containing them for antitumor treatment
KR950032205A (ko) 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용
RU2000100997A (ru) Производные 3-замещенного пиридо (3',4':4,5)тиено (2,3-d) пиримидина
PT82182A (fr) Nouveaux derives de la pyrrolo<1,2-a>azepinone leur preparation et les compositions pharmaceutiques qui les contiennent
RU2000100996A (ru) 3-замещенные производные 3,4-дигидро-тиено [2,3-d]пиримидина их получение и применение
FI891086A (fi) Menetelmä valmistaa farmakologisesti arvokkaita pyrido/3',4';4,5/syklohept/1,2-b/indolijohdannaisia
WO2000034286A3 (en) Process for the preparation of pyrimidinone derivatives